Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Sonoma Pharmaceuticals Inc
Inventory
Sonoma Pharmaceuticals Inc
Inventory Peer Comparison
Competitive Inventory Analysis
Latest Figures & CAGR of Competitors
Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
|
Inventory
$3m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
12%
|
|
Johnson & Johnson
NYSE:JNJ
|
Inventory
$11.4B
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
4%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Inventory
$3B
|
CAGR 3-Years
15%
|
CAGR 5-Years
18%
|
CAGR 10-Years
6%
|
|
Pfizer Inc
NYSE:PFE
|
Inventory
$10.9B
|
CAGR 3-Years
9%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
Merck & Co Inc
NYSE:MRK
|
Inventory
$6.5B
|
CAGR 3-Years
1%
|
CAGR 5-Years
3%
|
CAGR 10-Years
0%
|
|
Eli Lilly and Co
NYSE:LLY
|
Inventory
$6.1B
|
CAGR 3-Years
19%
|
CAGR 5-Years
15%
|
CAGR 10-Years
7%
|
See Also
What is Sonoma Pharmaceuticals Inc's Inventory?
Inventory
3m
USD
Based on the financial report for Dec 31, 2023, Sonoma Pharmaceuticals Inc's Inventory amounts to 3m USD.
What is Sonoma Pharmaceuticals Inc's Inventory growth rate?
Inventory CAGR 10Y
12%
Over the last year, the Inventory growth was 4%.